Epidemiology of avian infectious laryngotracheitis with special focus to South America: An update

Abstract

Avian Infectious laryngotracheitis (AILT) is a respiratory tract disease of great importance because it causes significant economic losses in the poultry industry around the world. It is caused by a Gallid herpesvirus type 1, a member of the genus Iltovirus. The target system for Avian Infectious Laryngotracheitis virus (AILTV) infections is the respiratory system, and the main organ in which the virus remains latent is the trigeminal ganglia. However, the virus has demonstrated tropism for other organs besides the respiratory tract. The main transmission routes are ocular and respiratory. Infected birds with clinical symptoms are main sources of transmission, but birds with latent infections, litter, and contaminated fomites may also transmit the virus. Clinical signs usually appear 6-12 days after natural exposure and may be moderate or severe. The causative agent of this disease can be propagated in chorioallantoic membrane (CAM) of developing chicken embryos and replicate in mature chicken kidney cells, as well as in a variety of epithelial chick embryo cells, such as kidneys, liver and lungs. There are several procedures for the diagnosis of ILT such as the observation of clinical signs, the detection of gross and histopathological lesions, and the use of molecular techniques, including RFLP, polymerase chain reaction (PCR), real-time PCR, and loop-mediated isothermal amplification. Vaccination with different types of vaccine provides a good expectation on disease control, such as vaccines produced in chicken-embryo-origin (CEO), tissue-culture-origin (TCO), and recombinant vaccines. However, in endemic areas, biosecurity measures and best management practices are important for the control of the disease. It is distributed worldwide and, in South America, it has been reported in Brazil, Peru, Ecuador, Bolivia, and Argentina causing great economic losses.